jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Pharmacology and PharmacotherapeuticsNOW IN
Article

Tumor lysis syndrome in multiple myeloma treated with bortezomib

K. M. Dhanraj1★, Dubashi Biswajit1★ Corresponding author

  1. 1Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Case Report.

CORRESPONDENCE

K. M. Dhanraj

Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Case Report.

dhannu_doc@rediffmail.com

Received: 17-02-2013; Revised: 10-09-2013; Accepted: 06-10-2013.

Volume 5, Issue 2 · pp. 161–162 · PUBLISHED 2014 · DOI: 10.4103/0976-500X.130091

View on JPP original site ↗

ABSTRACT

A 65 year old male diagnosed as multiple myeloma was started on bortezomib developed tumor lysis syndrome. Bortezomib induced tumor lysis is rare and suitable precautions should be considered in these patients.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Dhanraj, K. M., & Biswajit, D. (2014). Tumor lysis syndrome in multiple myeloma treated with bortezomib. Journal of Pharmacology and Pharmacotherapeutics, 5(2), 161–162. https://doi.org/10.4103/0976-500X.130091